Abstract:Cardiovascular dysfunction and heart failure associated with aging not only impairs the cardiac function but also the quality of life eventually decreasing the life expectancy of the elderly. Notably, cardiac tissue can prematurely age under certain conditions such as genetic mutation, persistent redox stress and overload, aberrant molecular signaling, DNA damage, telomere attrition, and other pathological insults. While cardiovascular-related morbidity and mortality is on the rise and remains a global health threat, there has been only little to moderate improvements in its medical management. This is due to the fact that the lifestyle changes to molecular mechanisms underlying age-related myocardial structure and functional remodeling are multifactorial and intricately operate at different levels. Along these lines, the intrinsic redox mechanisms and oxidative stress (OS) are widely studied in the myocardium. The accumulation of reactive oxygen species (ROS) with age and the resultant oxidative damage has been shown to increase the susceptibility of the myocardium to multiple complications such as atherosclerosis, hypertension, ischemic heart disease, cardiac myopathy, and heart failure. There has been growing interest in trying to enhance the mechanisms that neutralize the ROS and curtailing OS as a possible anti-aging intervention and as a treatment for age-related disorders. Natural defense system to fight against OS involves a master transcription factor named nuclear erythroid-2-p45-related factor-2 (Nrf2) that regulates several antioxidant genes. Compelling evidence exists on the Nrf2 gain of function through pharmacological interventions in counteracting the oxidative damage and affords cytoprotection in several organs including but not limited to lung, liver, kidney, brain, etc. Nevertheless, thus far, only a few studies have described the potential role of Nrf2 and its non-pharmacological induction in cardiac aging. This chapter explores the effects of various modes of exercise on Nrf2 signaling along with its responses and ramifications on the cascade of OS in the aging heart.

Nrf2 Connects Cellular Autophagy and Vascular Senescence in Atherosclerosis: A Mini-Review

Research Advance of Nrf2 on Atherosclerosis by Regulating Vascular Smooth Muscle Cell

The role of Nrf2 in oxidative stress-induced endothelial injuries

The Beneficial Role of Nrf2 in the Endothelial Dysfunction of Atherosclerosis

Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer.

Activation of Nrf2 inhibits atherosclerosis in ApoE-/- mice through suppressing endothelial cell inflammation and lipid peroxidation

Targeting the Nrf2 Pathway Against Cardiovascular Disease

NRF2-HIF2α Signaling Attenuates Endothelial Cell Senescence and Maintains Intercellular Junctions in Diabetes

NRF2 in age-related musculoskeletal diseases: Role and treatment prospects

The Role of Natural Products in Targeting Cardiovascular Diseases via Nrf2 Pathway: Novel Molecular Mechanisms and Therapeutic Approaches

Reduced NRF2 expression suppresses endothelial progenitor cell function and induces senescence during aging

Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases

Nrf2 and Heme Oxygenase-1 Involvement in Atherosclerosis Related Oxidative Stress

Nrf2: a dark horse in Alzheimer's disease treatment

Nrf2 at the heart of oxidative stress and cardiac protection

Nrf2-Mediated Cardiac Maladaptive Remodeling and Dysfunction in A Setting of Autophagy Insufficiency

Understanding the role of the cytoprotective transcription factor nuclear factor erythroid 2-related factor 2—lessons from evolution, the animal kingdom and rare progeroid syndromes

Nrf2-Keap1 in Cardiovascular Disease: Which is the Cart and Which the Horse?

Progress on Antioxidant Transcription Factor-Nrf2

Nrf2 and cardiovascular defense

Cardiac Aging - Benefits of Exercise, Nrf2 Activation and Antioxidant Signaling